ATH 11.1% 0.4¢ alterity therapeutics limited

This is a very interesting presentation and I think thier...

  1. 32 Posts.
    This is a very interesting presentation and I think thier position is somewhat understated

    They are confident of demonstrating 3 things in this IIa trial
    1.toxicity is OK
    2.neuro markers show positive results
    3.cognitive function improved

    The presenter stated that if 1 and 2 are shown they are in a strong position to partner and move on

    However what he didnt say was what would happen if evidence of 3 was shown and remember they have confidence in this as well even in this IIa trial
    What will happen if their is a suggestion that cognitive (read mental function) is improved? My opinion is that all hell will break lose-for this will be evidence that we have a potential therapy (not cure) for alzheimers disease. Although on the face of it further phase IIb and III would need to be done-there are all sorts of ways of accelerating a truly ground breaking therapy
    My opinion only!!!!!!!!!! As a share holder I may be so biased that my opinion is way off the mark so as always do you own research!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $14.55K 3.241M

Buyers (Bids)

No. Vol. Price($)
62 71906262 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 32338803 25
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.